NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Is It Time To Reassess Recursion Pharmaceuticals (RXRX) After Recent Share Price Weakness

If you are wondering whether Recursion Pharmaceuticals' current share price gives you enough value for the risk you are taking, you are not alone. The stock closed at US$4.67, with returns of 0.2% over the last 7 days, a 0.2% decline over 30 days, an 11.2% gain year to date, and a 28.5% decline over the past year, which can change how investors think about both potential and risk. Recent attention on Recursion has focused on its position within the pharmaceuticals and biotech space and how...
NasdaqGS:UAL
NasdaqGS:UALAirlines

How United’s New Preorder-Only Economy Meals Strategy at United Airlines (UAL) Has Changed Its Investment Story

United Airlines recently rolled out a preorder system for fresh Economy meals on flights over 1,190 miles, with preordering becoming the only way to buy these entrees from March 1, 2026, via its website and mobile app. This shift aims to cut food waste by more than 100,000 pounds annually while sharpening catering efficiency and tailoring choices to customer demand. We’ll now examine how this new meal preorder model, especially its focus on waste reduction and efficiency, could influence...